News for 'prescription drugs'

Prescription drugs still available online

Prescription drugs still available online

Rediff.com4 May 2015

The FDA Maharashtra on Friday lodged an FIR against Snapdeal.

Cough syrups to be available only with doctor's prescription

Cough syrups to be available only with doctor's prescription

Rediff.com16 Jun 2026

The Union Health Ministry has amended drug rules, making it mandatory to have a doctor's prescription for the sale of all syrups, including cough syrups. This move aims to enhance regulatory oversight and patient safety following concerns over drug quality and contamination-linked deaths.

Prescription drugs: The ticking time bomb

Prescription drugs: The ticking time bomb

Rediff.com2 Jul 2009

The sudden demise of King of Pop Michael Jackson has reopened a can of worms.

Interstate Drug Network Dismantled in Delhi, Four Arrested

Interstate Drug Network Dismantled in Delhi, Four Arrested

Rediff.com29 Mar 2026

Delhi Police dismantled an organised inter-state drug network, arresting four people and apprehending a juvenile, while seizing psychotropic substances worth over Rs 4.5 crore.

Maharashtra asks Snapdeal to stop selling prescription drugs

Maharashtra asks Snapdeal to stop selling prescription drugs

Rediff.com18 Apr 2015

Flipkart, Amazon, too, under radar

'Jacko had problems with prescription drugs'

'Jacko had problems with prescription drugs'

Rediff.com26 Jun 2009

Brian Oxman, who says that he has been the family's attorney for 20-years, though he disassociated himself from the defence team in 2005 during Jackson's molestation case, said that he had warned the singer's family members about the drug usage.

Interstate Spurious Drug Racket Busted In Delhi

Interstate Spurious Drug Racket Busted In Delhi

Rediff.com7 May 2026

Delhi Police have arrested four individuals involved in an interstate racket manufacturing and distributing counterfeit prescription drugs, uncovering an illegal processing unit in Delhi.

Obesity Drug Can't Be Advertised Anymore

Obesity Drug Can't Be Advertised Anymore

Rediff.com12 Mar 2026

'Any promotional activity carried out under the pretext of disease awareness, influencer engagement, corporate campaigns, or similar activities that create brand recall/product visibility of the prescription shall also be treated as violations.'

FDA Cracks Down On Hospital Pharmacies

FDA Cracks Down On Hospital Pharmacies

Rediff.com15 Jun 2026

'Hospitals sometimes compel patients to purchase medicines only from pharmacies owned by or attached to the hospital, refuse to provide prescriptions, withhold prescriptions, or send prescriptions directly to the hospital pharmacy without patient consent.'

Interstate Drug Network Busted In Delhi; Three Arrested

Interstate Drug Network Busted In Delhi; Three Arrested

Rediff.com14 May 2026

Delhi Police busted an interstate drug-supply network, arresting three persons, including a medical store owner and a medicine supplier, and recovering 17,800 Alprazolam tablets worth around Rs 3 lakh in central Delhi.

Haryana Boosts Anti-Narcotics Efforts with New Tech and Coordination

Haryana Boosts Anti-Narcotics Efforts with New Tech and Coordination

Rediff.com25 Mar 2026

Haryana is strengthening its anti-narcotics framework with an integrated and technology-driven roadmap, focusing on increased enforcement, inter-state coordination, and financial disruption of drug networks.

Centre Cracks Down on GLP-1 Drug Misuse

Centre Cracks Down on GLP-1 Drug Misuse

Rediff.com25 Mar 2026

Inspections conducted across 49 entities including pharmacies, wholesalers, and clinics to detect violations and misleading marketing practices.

Illegal Medicine Racket Busted In Delhi; Drugs Seized

Illegal Medicine Racket Busted In Delhi; Drugs Seized

Rediff.com21 Apr 2026

The Delhi government's Drugs Control Department dismantled an illegal medicine sale operation in Shahdara, seizing a significant quantity of drugs and expired items.

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Rediff.com9 Apr 2026

'The unregulated marketing has to stop. People are getting recommendations for this from gym trainers, from marriage counsellors -- that is simply unacceptable.' ''There are many ways to lose weight -- eat less, fast, exercise, eat healthy. That is how you lose weight.'

Maharashtra FDA Seizes Illegal Medicines Worth Over Rs 24 Lakh In Major Crackdown

Maharashtra FDA Seizes Illegal Medicines Worth Over Rs 24 Lakh In Major Crackdown

Rediff.com9 Jun 2026

The Maharashtra Food and Drug Administration (FDA) conducted three separate operations in Pune and Kolhapur, seizing illegal medicines worth over Rs 24 lakh. Actions included seizing allopathic medicines from an unlicensed firm and prescription drugs with improper promotional packaging, with the FDA vowing strict action against violators.

Slimming Drug Boom Sparks Misuse Concerns: 'They Are Not Meant For Cosmetic Weight Loss'

Slimming Drug Boom Sparks Misuse Concerns: 'They Are Not Meant For Cosmetic Weight Loss'

Rediff.com20 Apr 2026

The fast-growing GLP-1 market, propelled by lower-cost generics following patent expiry, is widening availability beyond patients with obesity and diabetes -- but also driving unsupervised, appearance-led demand, according to doctors.

Weight Loss Drugs Set to Flood India

Weight Loss Drugs Set to Flood India

Rediff.com16 Mar 2026

While the introduction of branded generics is likely to accelerate volumes for GLP-1 agonists, value growth may moderate because of price erosion.

Indian Pharma Bets Beyond US Generics

Indian Pharma Bets Beyond US Generics

Rediff.com4 days ago

Companies are investing heavily in complex injectables, respiratory therapies and biosimilars to improve margins and diversify portfolios.

Tripura Police File Charge Sheet In Phensedyl Smuggling Case

Tripura Police File Charge Sheet In Phensedyl Smuggling Case

Rediff.com24 May 2026

Tripura Police's Crime Branch has filed a charge sheet against six individuals in connection with a Phensedyl smuggling case, following the seizure of a large quantity of the banned substance last year.

How India Can Create 100 Million New Jobs In 7 Years!

How India Can Create 100 Million New Jobs In 7 Years!

Rediff.com4 Jun 2026

TeamLease Co-founder Manish Sabharwal on why regulatory cholesterol is killing India's entrepreneurial engine -- and how we can fix it and generate 100 million jobs in India in just about 7 years.

Cipla's Q4 Revenue Below Estimates, Strategic Launches Crucial for Recovery

Cipla's Q4 Revenue Below Estimates, Strategic Launches Crucial for Recovery

Rediff.com22 May 2026

Pharmaceutical major Cipla reported a 3 per cent year-on-year decline in March quarter revenue to Rs 6,541 crore, with net profit falling 55 per cent to Rs 554.6 crore, missing consensus estimates. Despite strong growth in India and Africa, a significant decline in North American sales impacted overall performance, with the company now focusing on new product launches and regulatory filings to drive future gains.

India To Criminalise Doping Supply Chain With Jail Terms

India To Criminalise Doping Supply Chain With Jail Terms

Rediff.com21 May 2026

The National Anti-Doping Act will be modified to criminalise trafficking and distribution of prohibited substances to athletes, with jail terms of up to five years for suppliers.

India To Criminalise Supply Of Banned Substances To Athletes

India To Criminalise Supply Of Banned Substances To Athletes

Rediff.com21 May 2026

India is set to amend its National Anti-Doping Act to criminalise the trafficking and distribution of prohibited substances to athletes, with potential jail terms for suppliers, including medical practitioners who knowingly prescribe banned drugs. The amendments are open for public feedback until June 18 and are expected to be tabled in the monsoon session of Parliament.

Want To Be A Mounjaro Bride: Is It Worth It?

Want To Be A Mounjaro Bride: Is It Worth It?

Rediff.com26 May 2026

'Don't chase unrealistic expectations or compare yourself to social media transformations.' 'Focus on your health first, not just the number on the scale before the wedding.'

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Rediff.com14 May 2025

A fresh US executive order (EO) which seeks to bring down prices of prescription drugs in the country by up to 90 per cent -- on par with other developed nations -- will affect innovator companies, while sparing the Indian generic drug makers in the short term. US President Donald Trump signed the EO on Monday, directing the US Trade Representative and the Secretary of Commerce to act against foreign countries that "purposefully and unfairly undercut market prices", driving price hikes in the US.

Centre mandates blue strip on antimicrobial drugs to curb overuse

Centre mandates blue strip on antimicrobial drugs to curb overuse

Rediff.com24 Jan 2026

The Union health ministry has issued draft rules to mandate a blue vertical strip on all antimicrobial drug labels, aiming to rein in over-the-counter misuse and tackle India's growing antimicrobial resistance (AMR) problem.

Truth Behind Weight Loss Drugs Like Ozempic, Mounjaro: A Doctor Explains

Truth Behind Weight Loss Drugs Like Ozempic, Mounjaro: A Doctor Explains

Rediff.com17 Feb 2026

'Weight loss drugs can be life changing but are not without risks,' says Dr Vishnu Radhakrishnan as he explains the truth behind Ozempic and Mounjaro.

Weightloss Drugs Hit 1,000 Crore Mark

Weightloss Drugs Hit 1,000 Crore Mark

Rediff.com22 Dec 2025

'As more patients are prescribed these drugs, intolerance due to gastrointestinal and other side effects will become more visible, leading to higher discontinuation rates.'

Amazon Directors Get Relief in Illegal Abortion Pill Sale Case

Amazon Directors Get Relief in Illegal Abortion Pill Sale Case

Rediff.com11 Mar 2026

A sessions court in Mumbai has quashed notices issued against two directors of Amazon Seller Services Private Limited for the alleged illegal online sale of abortion pills, citing that Amazon acts as a platform and not the seller.

Can MFN Pricing Reshape India-US Pharma Equation?

Can MFN Pricing Reshape India-US Pharma Equation?

Rediff.com5 Jun 2025

US accounts for a large part of revenue for top Indian pharma companies like Gland Pharma (54 percent), Dr Reddy's (53 per cent), and Aurobindo Pharma (48 per cent).

Women commission to probe egg extraction racket as chilling details emerge

Women commission to probe egg extraction racket as chilling details emerge

Rediff.com27 Feb 2026

The Maharashtra State Women's Commission is investigating a major illegal human egg extraction racket in Thane district, where vulnerable women were exploited for multiple donation cycles using forged documents. The investigation revealed unauthorized IVF clinic operations and unqualified individuals administering medical procedures.

Trump's drug price cut plan may put pressure on India

Trump's drug price cut plan may put pressure on India

Rediff.com12 May 2025

US President Donald Trump's plan to sign an executive order to cut prescription drug prices by 30-80 per cent could lead to a global price adjustment with pharma firms pushing lower-cost countries like India to raise prices, according to the economic think tank GTRI. The US move could push prices in lower-cost countries like India as manufacturers would seek to recover losses and R&D costs from these nations.

At Davos, Trump rules out force to take Greenland, but warns allies

At Davos, Trump rules out force to take Greenland, but warns allies

Rediff.com21 Jan 2026

Trump called for immediate negotiations for the US to acquire Greenland from Denmark, describing the country as ungrateful, during his speech at Davos.

Multinational pharma cos, Indian drugmakers diverge to mutual gain: How win-win is it?

Multinational pharma cos, Indian drugmakers diverge to mutual gain: How win-win is it?

Rediff.com11 Mar 2026

For decades, multinational pharmaceutical companies and Indian drugmakers worked in ways that supported each other: MNCs brought innovation and brands, while Indian companies built scale through generics and cost efficiency. There was an important overlap - generic drugs - but this is shrinking fast. And the consequences are reshaping India's gigantic pharmaceutical market.

50% medical prescriptions in India deviated from guidelines: Study

50% medical prescriptions in India deviated from guidelines: Study

Rediff.com10 Jul 2024

Nearly one in every two medical prescriptions issued in India deviated from standard guidelines, with approximately a tenth showing 'unacceptable deviations', a study, conducted by a team of researchers including those at the All India Institute of Medical Sciences (AIIMS) in New Delhi, has found.

UP cracks down on illegal cough syrup trade, 75 arrested

UP cracks down on illegal cough syrup trade, 75 arrested

Rediff.com20 Dec 2025

Uttar Pradesh authorities have registered 74 cases and arrested 75 people in connection with the illegal storage and sale of codeine-based cough syrup. A minister alleges links to the Samajwadi Party and an SIT is investigating.

Pharma cos may see short-term price blip: Ind-Ra

Pharma cos may see short-term price blip: Ind-Ra

Rediff.com27 Aug 2025

Any potential tariffs on pharmaceutical imports into the US are unlikely to impact the credit profiles of Indian firms except for a short-term pricing blip, according to a report by India Ratings and Research (Ind-Ra). The report stated that the US generics market contributes around 35 per cent to the total revenue of the leading Indian pharma firms.

AI System To Transform Training, Injury Tracking In Indian Sports

AI System To Transform Training, Injury Tracking In Indian Sports

Rediff.com20 Feb 2026

India launches AI-driven SPEEED platform to track athlete performance, predict injuries, tackle age fraud and revolutionise sports science nationwide.

Cough syrup deaths: Many states ban Coldrif; MP suspends officials

Cough syrup deaths: Many states ban Coldrif; MP suspends officials

Rediff.com7 Oct 2025

A special investigation team (SIT) has been formed in Madhya Pradesh to investigate the deaths of 14 children in Chhindwara, suspected to be linked to a toxic cough syrup. The investigation includes arrests, exhumations, and a ban on the implicated cough syrup.

SC bars stem cell therapy for autism outside clinical trials

SC bars stem cell therapy for autism outside clinical trials

Rediff.com30 Jan 2026

The Supreme Court of India has ruled that stem cell therapies for Autism Spectrum Disorder (ASD) can only be offered within approved and monitored clinical trial settings, deeming any other use unethical and potentially malpractice.